Can Topamax (topiramate) cause hair loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Topamax (Topiramate) and Hair Loss

Yes, Topamax (topiramate) can cause hair loss, and patients should be informed about this potential side effect before starting treatment. 1

Evidence from FDA Drug Labeling

The FDA-approved prescribing information for topiramate explicitly lists alopecia (hair loss) as a documented adverse effect: 2

  • In pediatric patients (ages 2-16 years) receiving topiramate as add-on epilepsy therapy, alopecia occurred in 1-2% of patients 2
  • In adult monotherapy epilepsy trials, alopecia occurred in 2-5% of patients in the 400 mg/day group 2
  • Hair loss is classified as an "infrequent" adverse event (occurring in 1/100 to 1/1000 patients) in the comprehensive safety database 2

Clinical Guideline Recommendations

When topiramate is used for migraine prophylaxis or epilepsy treatment, patients must be informed about the potential risk of hair loss as a side effect. 1

  • For patients requiring topiramate for seizure control or migraine prevention where alternatives are limited, the benefits of continued treatment may outweigh the cosmetic concerns of hair loss 1
  • When topiramate is used for obesity management (such as in the combination product phentermine/topiramate ER), the risk of hair loss should be weighed against the potential benefits 1

Characteristics of Topiramate-Induced Hair Loss

The pattern and reversibility of topiramate-induced alopecia have specific features: 3

  • Hair loss is typically diffuse and non-scarring 3
  • Telogen effluvium (a form of temporary hair loss) is the most common mechanism 3
  • A characteristic feature is the reversibility of alopecia after topiramate dose adjustment or discontinuation 3, 4
  • In a comprehensive literature review, 13 cases of topiramate-induced alopecia have been formally reported 3

Clinical Context and Mechanism

Drug-induced hair loss generally occurs through toxic effects on the hair matrix: 4

  • The type of hair loss depends on the drug, its dosage, and patient susceptibility 4
  • Drug-induced hair loss is usually reversible upon discontinuation or dose reduction 4, 5

Important Caveats

Before attributing hair loss to topiramate, exclude other potential triggers: 5

  • Fever, hemorrhage, severe illness, stress, and childbirth can all cause telogen effluvium 5
  • A thorough exclusion of these confounders is necessary before blaming the medication 5

Practical Management Approach

For patients experiencing hair loss on topiramate:

  • Document the temporal relationship between starting topiramate and onset of hair loss 5
  • Consider dose reduction if clinically appropriate, as alopecia shows dose-related reversibility 3
  • Specialist dermatology consultation is recommended for patients reporting significant hair loss 3
  • If topiramate is being used for weight management, consider alternative FDA-approved weight loss medications that do not carry this risk 1

References

Guideline

Topiramate-Induced Hair Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antiseizure Medication-Induced Alopecia: A Literature Review.

Medicines (Basel, Switzerland), 2023

Research

Drug reactions affecting hair: diagnosis.

Dermatologic clinics, 2007

Research

Drugs and hair loss.

Dermatologic clinics, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.